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Abstract: 
Locating high affinity binding sites of the carcinogen 4-nitro-quinoline-1-oxide on phiX174 
DNA using restriction enzyme activity assays 
Previous NMR and optical titration studies have suggested that the carcinogen 4-
nitroquinoline-1-oxide [NQO] exhibits a high degree of selectivity in its binding to DNAs. 
Restriction enzyme activity assays have been employed to probe the sequence selectivity of a 
variety of compounds, including the carcinogen acetoxyacetylaminofluorene, to DNAs. To 
further examine sequence selectivity in the binding of NQO DNA, we have examined the 
binding of NQO to various locations on the sequenced DNA phiX174. In this study , several 
restriction enzymes, chosen to have different reaction sequences, have been used to examine the 
binding of NQO to the differing locations on the DNA phiX174. Samples of the DNA are 
reacted with varying concentrations of NQO and then digested with one of the restriction 
enzymes chosen to cleave phiX174 RF DNA once or twice.  The digestion products are then 
separated on electrophoresis agarose gels. From the relative intensities of starting [undigested] 
DNA gel bands and digestion product gel bands enhancement or inhibition of cleavage by the 
bound NQO can be observed. The results of the digestions with the different enzymes are 
compared to detect sequence selectivity. For example, with the enzyme DraI [cleavage sequence 
TTTAAA], NQO showed enhancement of enzyme cleavage activity. In contrast, NQO produced 
inhibition at the enzyme XhoI site [CTCGAG]. The results of these experiments show that NQO 
shows selectivity in its binding activity on phiX174 DNA. When the sequence locations where 
this carcinogen binds to DNA are located, then we can examine the binding to those specific 
sequences in detail.  These sequences can also be compared to the determined sequences for 
other carcinogens to provide understanding into how carcinogens, in general, act on the DNA. 
